冷冻疗法治疗慢性鼻炎:随机假手术对照试验的3个月结果
这项前瞻性多中心随机假手术对照患者盲法试验纳入133例中重度慢性鼻炎成人,比较冷冻疗法与假手术在90天时的应答率。结果显示冷冻组应答率73.4%,假手术组36.5%(p<0.001),且症状评分与生活质量改善更优。
要点
- 冷冻疗法90天应答率显著高于假手术(73.4% vs 36.5%,p<0.001)
- rTNSS、RQLQ(S)和NOSE评分改善均优于假手术(p<0.001)
- 报告1例严重手术相关不良事件:焦虑/惊恐发作
核心结论
- 冷冻疗法在改善慢性鼻炎症状和生活质量方面优于假手术。
研究设计与样本
- 前瞻性、多中心、1:1随机、假手术对照、患者盲法试验。
- 预定样本量为每组61例,实际12个美国研究中心入组133例。
- 主要终点分析纳入127例(冷冻组64例,假手术组63例)有90天结果者。
- 入组标准为局部麻醉下适合冷冻疗法的中重度慢性鼻炎成人,要求rTNSS总分≥4、流涕≥2、鼻塞≥1。
主要发现
- 90天随访时冷冻组应答率为73.4%(47/64),假手术组为36.5%(23/63),p<0.001。
- 应答者定义为rTNSS相对基线降低30%或以上的参与者。
- 90天随访时冷冻组在rTNSS、RQLQ(S)和NOSE评分上的改善均大于假手术组(p<0.001)。
- 报告1例严重手术相关不良事件:焦虑/惊恐发作。
关键数值与推荐
- 主要终点为90天时治疗组与假手术组应答者百分比的比较。
- 应答者定义为rTNSS相对基线降低≥30%。
- 入组要求rTNSS总分≥4、流涕评分≥2、鼻塞评分≥1。
- 随访 visits 在术后30天和90天进行。
临床怎么用
- 冷冻疗法可作为中重度慢性鼻炎患者改善症状和生活质量的候选治疗选择。
- 临床决策时可参考90天应答率数据与假手术对照的优效性结果。
- 需关注手术相关不良事件,包括焦虑/惊恐发作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to test whether cryotherapy is superior to a sham procedure for reducing symptoms of chronic rhinitis. METHODS: This study was a prospective, multicenter, 1:1 randomized, sham-controlled, patient-blinded trial. The predetermined sample size was 61 participants per arm. Adults with moderate/severe symptoms of chronic rhinitis who were candidates for cryotherapy under local anesthesia were enrolled. Participants were required to have minimum reflective Total Nasal Symptom Scores (rTNSSs) of 4 for total, 2 for rhinorrhea, and 1 for nasal congestion. Follow-up visits occurred at 30 and 90 days postprocedure. Patient-reported outcome measures included the rTNSS, standardized Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ(S)], and Nasal Obstruction Symptom Evaluation (NOSE) questionnaires. Adverse events were also recorded. The primary endpoint was the comparison between the treatment and sham arms for the percentage of responders at 90 days. Responders were defined as participants with a 30% or greater reduction in rTNSS relative to baseline. RESULTS: Twelve US investigational centers enrolled 133 participants. The primary endpoint analysis included 127 participants (64 active, 63 sham) with 90-day results. The treatment arm was superior at the 90-day follow-up with 73.4% (47 of 64) responders compared with 36.5% (23 of 63) in the sham arm (p < 0.001). There were greater improvements in the rTNSS, RQLQ(S), and NOSE scores for the active arm over the sham arm at the 90-day follow-up (p < 0.001). One serious procedure-related adverse event of anxiety/panic attack was reported. CONCLUSION: Cryotherapy is superior to a sham procedure for improving chronic rhinitis symptoms and patient quality of life.
引用
- Del Signore AG, Greene JB, Russell JL, et al. Cryotherapy for treatment of chronic rhinitis: 3-month outcomes of a randomized, sham-controlled trial. Int Forum Allergy Rhinol. 2021. PMID: 34355872. doi:10.1002/alr.22868
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。